Your browser doesn't support javascript.
loading
Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases.
Sundaresan, Yogapriya; Yacoub, Sam; Kodati, Bindu; Amankwa, Charles E; Raola, Akash; Zode, Gulab.
Affiliation
  • Sundaresan Y; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Yacoub S; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Kodati B; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Amankwa CE; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Raola A; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Zode G; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
FEBS J ; 290(22): 5248-5269, 2023 Nov.
Article in En | MEDLINE | ID: mdl-36877952
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2023 Type: Article Affiliation country: United States